NCT06197802 2025-07-31
Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women
Xiamen University
Active not recruiting
Clinical Trials
15 trialsNCT05056402 2025-07-22
An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old
Xiamen University
Phase 3 Active not recruiting
NCT06915779 2025-04-08
Long Term Follow-up of HPV Vaccine in HIV (CTN 236)
University of British Columbia
Completed
NCT06700941 2024-11-22
Impact of HPV Vaccination Against Cervical Lesions and Genital Warts in Colombia. an Ecological Assessment
Universidad Nacional de Colombia
Completed
NCT06681636 2024-11-08
HPV9vxFSW
National Institute of Hygiene and Epidemiology, Vietnam
Phase 2 Not yet recruiting
NCT04782895 2023-06-15
Immunogenicity of a Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58)Vaccine(E.Coli) Versus Gardasil®9 in Healthy Females 18-26 Years of Age
Xiamen University
Phase 3 Completed
NCT04905030 2021-06-11
Education, Immigration and HPV Vaccination: an Informational Randomized Trial
Karolinska Institutet
Phase NA Unknown
NCT03813940 2021-04-08
Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
Xiamen University
Phase 1 Completed
NCT03935204 2021-04-08
Immunogenicity Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
Xiamen University
Phase 2 Completed
NCT02558803 2016-05-25
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3
Regenstrief Institute, Inc.
Phase NA Completed
NCT02551887 2016-03-11
HPV Vaccination: An Investigation of Physician Reminders and Recommendation Scripts
Regenstrief Institute, Inc.
Phase NA Completed
NCT02276521 2015-09-23
Evaluation of Long Term Immunity Following HPV Vaccination
Murdoch Childrens Research Institute
Completed
NCT00501137 2015-04-10
BCGov-01
University of British Columbia
Phase 3 Completed
NCT00862810 2014-11-20
ADS
Duke University
Phase 4 Completed
NCT02280642 2014-10-31
ADS
Duke University
Completed